Breaking News
Get 40% Off 0
🤯 Perficient is up a mind-blowing 53%. Our ProPicks AI saw the buying opportunity in March. Read full update

Search Results for "MSD":

Results: 201

Quotes

MSD Morgan Stanley Emerging Markets Debt Closed Fund Stock - NYSE equities MSDL Morgan Stanley Direct Lending Fund Stock - NYSE equities MSDU Amundi Index Solutions - Amundi Index MSCI Emerging Markets SRI PAB UCITS ETF DR D ETF - London etf MSDG Amundi Index Solutions - Amundi Index MSCI Emerging Markets SRI PAB UCITS ETF DR D ETF - London etf MSDc1 Silver Mini Futures Commodity - MCX commodity MSDc2 Silver Mini Futures Commodity - MCX commodity MSDc3 Silver Mini Futures Commodity - MCX commodity MSDc4 Silver Mini Futures Commodity - MCX commodity
Show all (10)

News

Jefferies initiates UL Solutions stock at Buy, sets price target
By Investing.com

On Tuesday, UL Solutions Inc (NYSE:ULS) received a positive outlook from a major financial services firm. Jefferies initiated coverage on the company with a Buy rating and set a price target of...

JPMorgan raises Mister Car Wash stock target, upgrades to overweight
By Investing.com

On Friday, JPMorgan made a significant adjustment to its outlook on Mister Car Wash Inc. (NYSE:MCW), shifting the stock's rating from Neutral to Overweight. The firm also set a new price target of...

JPMorgan cuts Driven Brands stock target
By Investing.com

On Friday, JPMorgan adjusted its stance on Driven Brands (NASDAQ:DRVN), downgrading the stock from Overweight to Neutral and reducing the price target to $12.50 from the previous $18.00. The firm's...

Show all (159)

Analysis

McKesson (MCK) Acquires Medical Specialties For $800 Million
By Zacks Investment Research

McKesson Corporation (MCK) recently completed its previously-announced acquisition of Medical Specialties Distributors (MSD) for a value of $800 million. The deal is part of a continuing effort by...

Immutep: Merck Collaboration Opens New Opportunities
By Edison

Immutep Ltd ADR (NASDAQ:Merk) & Co (MSD) for a Phase II study to evaluate eftilagimod alpha (IMP321) plus Keytruda in lung, head and neck and ovarian cancers. It is positive to see Immutep...

Immutep: A Second Big Pharma Collaboration For Efti
By Edison

Immutep Ltd ADR (NASDAQ:IMMP) has entered into a clinical trial collaboration and supply agreement with Merck/Pfizer to investigate the combination of its APC activator eftilagimod alpha (efti) with...

Show all (32)
Results: 10

Refine Results

Instrument Type

Region

 

Country

Exchange

Sector

 

Industry

 
Results: 159

Refine Results

Date

Date
 

Category

Provider

 

News

{{title}}
By {{provider}}

{{content}}

Please try another search

Results: 32

Refine Results

Date

Date
 

Category

Author

Analysis

{{title}}
By {{provider}}

{{content}}

Results: 0

Refine Results

Country

Importance

Economic Events

Results: 0

Tools & Sections

Results: 0

Authors

Continue with Google
or
Sign up with Email